Olema Pharmaceuticals, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€155.24K - Gross profit
€0.00 - SG&A expenses
€14.56M - R&D expenses
€119.46M - EBITDA
-€133.73M - D&A
€289.15K - EBIT
-€134.02M - Interest expenses
€0.00 - EBT
-€121.37M - Tax expenses
€2.86M - Net income
-€121.37M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€4.33M - Changes in working capital
-€1.09M - Operating cash flow
-€108.46M - Capex
-€135.62K - Other investing cash flow
-€135.62K - Net investing cash flow
-€67.68M - Total cash dividends paid
€0.00 - Issuance of common stock
€187.46M - Debt repayment
€0.00 - Other financing cash flow
-€1.20M - Net financing cash flow
€206.50M - Foreign exchange effects
€0.00 - Net change in cash
€30.35M - Cash at end of period
€44.76M - Free cash flow
-€108.60M
Balance sheet
- Cash and cash equivalents
€44.76M - Cash and short-term investments
€308.69M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€4.96M - Total current assets
€313.65M - Property, plant & equipment
€1.44M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€10.74M - Total non-current assets
€12.18M - Total assets
€325.83M - Accounts payable
€796.66K - Short-term debt
€983.45K - Other current liabilities
€26.51M - Total current liabilities
€28.29M - Long-term debt
€513.48K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€2.56M - Total non-current liabilities
€3.07M - Total liabilities
€31.36M - Common stock
€5.97K - Retained earnings
-€434.39M - Other equity
€267.83K - Total equity
€294.47M - Total liabilities and shareholders' equity
€325.83M
Company information
- Market capitalization
€269.62M - Employees
96 - Enterprise Value
€229.67M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-41.2% Much better than peer group: -107.5% - ROA
-
-37.2% Even with peer group: -40.2% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-40.2% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€1.26M